Patents by Inventor Yuxun Wang
Yuxun Wang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20220056425Abstract: The present disclosure provides T7 RNA polymerase variants with enhanced transcriptional activity, and methods of using such variants to produce modified oligonucleotides, such as 2?-modified oligonucleotides. These polymerase variants and methods thereof improve the transcription yield of modified oligonucleotides.Type: ApplicationFiled: September 12, 2019Publication date: February 24, 2022Inventors: Kristin THOMPSON, Yuxun WANG, Shuhao ZHU
-
Publication number: 20210230578Abstract: The present invention describes methods of removing DNA from an RNA transcript during the mRNA production process. The method embodies procedures for obtaining an in vitro transcription product, and removing any DNA from the product. The DNA can be removed by adding either free DNase or a resin containing immobilized DNase to the product, and recovering the RNA transcript. Alternatively, the DNA template used in the in vitro transcription reaction is labeled. After transcription, the product is applied to a resin that is configured to bind the label, and the RNA transcript is recovered. To detect whether any residual impurities are left in the RNA transcript product, the product is subjected to nuclease digestion and subsequently to liquid chromatography-tandem mass spectrometry analysis to quantitate any residual DNA. The present invention demonstrates efficient and effective methods of isolating an RNA transcript from an in vitro transcription product.Type: ApplicationFiled: December 7, 2020Publication date: July 29, 2021Inventors: William Joseph ISSA, Yuxun WANG, Stephane BANCEL
-
Patent number: 10858647Abstract: The present invention describes methods of removing DNA from an RNA transcript during the mRNA production process. The method embodies procedures for obtaining an in vitro transcription product, and removing any DNA from the product. The DNA can be removed by adding either free DNase or a resin containing immobilized DNase to the product, and recovering the RNA transcript. Alternatively, the DNA template used in the in vitro transcription reaction is labeled. After transcription, the product is applied to a resin that is configured to bind the label, and the RNA transcript is recovered. To detect whether any residual impurities are left in the RNA transcript product, the product is subjected to nuclease digestion and subsequently to liquid chromatography-tandem mass spectrometry analysis to quantitate any residual DNA. The present invention demonstrates efficient and effective methods of isolating an RNA transcript from an in vitro transcription product.Type: GrantFiled: July 30, 2018Date of Patent: December 8, 2020Assignee: ModernaTX, Inc.Inventors: William Joseph Issa, Yuxun Wang, Stephane Bancel
-
Patent number: 10669252Abstract: Disclosed are a benzazepine derivative, a preparation method, a pharmaceutical composition and the use thereof. A compound as shown in formula (I) of the present invention, and an isomer, a prodrug, a stable isotope derivative or a pharmaceutically acceptable salt thereof have the following structure. The benzazepine derivative of the present invention has a good regulation effect on the TLR family and the related signaling pathway, and in particular, has a good regulation effect on TLR8, can effectively treat, relieve and/or prevent various diseases mediated by TLR family and the TLR-related signaling pathway, and in particular, can effectively treat, relieve and/or prevent various diseases mediated by TLR8, such as cancers, autoimmune diseases, infections, inflammations, transplantation rejections, graft-versus-host diseases, etc.Type: GrantFiled: May 4, 2017Date of Patent: June 2, 2020Assignee: SHANGHAI DE NOVO PHARMATECH CO., LTD.Inventors: Daxin Gao, Yuxun Wang, Shoujun Chen, Heping Yang
-
Publication number: 20190152941Abstract: Disclosed are a benzazepine derivative, a preparation method, a pharmaceutical composition and the use thereof. A compound as shown in formula (I) of the present invention, and an isomer, a prodrug, a stable isotope derivative or a pharmaceutically acceptable salt thereof have the following structure. The benzazepine derivative of the present invention has a good regulation effect on the TLR family and the related signaling pathway, and in particular, has a good regulation effect on TLR8, can effectively treat, relieve and/or prevent various diseases mediated by TLR family and the TLR-related signaling pathway, and in particular, can effectively treat, relieve and/or prevent various diseases mediated by TLR8, such as cancers, autoimmune diseases, infections, inflammations, transplantation rejections, graft-versus-host diseases, etc.Type: ApplicationFiled: May 4, 2017Publication date: May 23, 2019Applicant: SHANGHAI DE NOVO PHARMATECH CO., LTD.Inventors: Daxin GAO, Yuxun WANG, Shoujun CHEN, Heping YANG
-
Publication number: 20190100748Abstract: The present invention describes methods of removing DNA from an RNA transcript during the mRNA production process. The method embodies procedures for obtaining an in vitro transcription product, and removing any DNA from the product. The DNA can be removed by adding either free DNase or a resin containing immobilized DNase to the product, and recovering the RNA transcript. Alternatively, the DNA template used in the in vitro transcription reaction is labeled. After transcription, the product is applied to a resin that is configured to bind the label, and the RNA transcript is recovered. To detect whether any residual impurities are left in the RNA transcript product, the product is subjected to nuclease digestion and subsequently to liquid chromatography-tandem mass spectrometry analysis to quantitate any residual DNA. The present invention demonstrates efficient and effective methods of isolating an RNA transcript from an in vitro transcription product.Type: ApplicationFiled: July 30, 2018Publication date: April 4, 2019Inventors: William Joseph ISSA, Yuxun WANG, Stephane BANCEL
-
Patent number: 10077439Abstract: The present invention describes methods of removing DNA from an RNA transcript during the mRNA production process. The method embodies procedures for obtaining an in vitro transcription product, and removing any DNA from the product. The DNA can be removed by adding either free DNase or a resin containing immobilized DNase to the product, and recovering the RNA transcript. Alternatively, the DNA template used in the in vitro transcription reaction is labeled. After transcription, the product is applied to a resin that is configured to bind the label, and the RNA transcript is recovered. To detect whether any residual impurities are left in the RNA transcript product, the product is subjected to nuclease digestion and subsequently to liquid chromatography-tandem mass spectrometry analysis to quantitate any residual DNA. The present invention demonstrates efficient and effective methods of isolating an RNA transcript from an in vitro transcription product.Type: GrantFiled: March 13, 2014Date of Patent: September 18, 2018Assignee: ModernaTX, Inc.Inventors: William Joseph Issa, Yuxun Wang, Stephane Bancel
-
Patent number: 9790531Abstract: The invention relates to compositions and methods for the design, evolution, preparation, and/or manufacture of enzymes for use with polynucleotides, primary transcripts and mmRNA molecules.Type: GrantFiled: November 18, 2016Date of Patent: October 17, 2017Assignee: ModernaTX, Inc.Inventors: Yuxun Wang, Divakar Ramakrishnan, Antonin De Fougerolles, Susan Whoriskey
-
Publication number: 20170130255Abstract: The invention relates to compositions and methods for the design, evolution, preparation, and/or manufacture of enzymes for use with polynucleotides, primary transcripts and mmRNA molecules.Type: ApplicationFiled: November 18, 2016Publication date: May 11, 2017Applicant: ModernaTX, Inc.Inventors: Yuxun Wang, Divakar Ramakrishnan, Antonin De Fougerolles, Susan Whoriskey
-
Patent number: 9512456Abstract: The invention relates to compositions and methods for the design, evolution, preparation, and/or manufacture of enzymes for use with polynucleotides, primary transcripts and mmRNA molecules.Type: GrantFiled: August 13, 2013Date of Patent: December 6, 2016Assignee: ModernaTX, Inc.Inventors: Yuxun Wang, Divakar Ramakrishnan, Antonin de Fougerolles, Susan Whoriskey
-
Publication number: 20160024492Abstract: The present invention describes methods of removing DNA from an RNA transcript during the mRNA production process. The method embodies procedures for obtaining an in vitro transcription product, and removing any DNA from the product. The DNA can be removed by adding either free DNase or a resin containing immobilized DNase to the product, and recovering the RNA transcript. Alternatively, the DNA template used in the in vitro transcription reaction is labeled. After transcription, the product is applied to a resin that is configured to bind the label, and the RNA transcript is recovered. To detect whether any residual impurities are left in the RNA transcript product, the product is subjected to nuclease digestion and subsequently to liquid chromato graphy-tandem mass spectrometry analysis to quantitate any residual DNA. The present invention demonstrates efficient and effective methods of isolating an RNA transcript from an in vitro transcription product.Type: ApplicationFiled: March 13, 2014Publication date: January 28, 2016Applicant: MODERNA THERAPEUTICS, INC.Inventors: William Joseph ISSA, Yuxun WANG, Stephane BANCEL
-
Publication number: 20150211039Abstract: The invention relates to compositions and methods for the design, evolution, preparation, and/or manufacture of enzymes for use with polynucleotides, primary transcripts and mmRNA molecules.Type: ApplicationFiled: August 13, 2013Publication date: July 30, 2015Inventors: Yuxun Wang, Divakar Ramakrishnan, Antonin de Fougerolles, Susan Whoriskey
-
Publication number: 20090142855Abstract: The present invention relates to the primate family of cytokines. Provided herein are polynucleotides encoding such polypeptides, and reagents useful for producing the encoded polypeptides in a host source, and for identifying compounds which bind and modulate the activity of the encoded polypeptides. Also provided are reagents useful for the diagnosis or treatment of inflammatory and/or autoimmune related diseases in primates.Type: ApplicationFiled: June 30, 2006Publication date: June 4, 2009Inventors: Wei Tang, Yuxun Wang, Shuhao Zhu